|
3-chloro-5-hydroxy BA
|
3-氯-5-羥基苯甲酸
|
53984-36-4
|
|
Ombitasvir
|
奧比他韋
|
1258226-87-7
|
|
ASP2535
|
4-[3-(1-Methylethyl)-5-(6-phenyl-3-pyridinyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole
|
374886-51-8
|
|
GRK6-IN-1
|
化合物 GRK6-IN-1
|
2677786-61-5
|
|
Bitopertin
|
(S)-[4-(3-氟-5-三氟甲基吡啶-2-基)哌嗪-1-基][5-(甲磺酰基)-2-(2,2,2-三氟-1-甲基乙氧基)苯基]甲酮
|
845614-11-1
|
|
LY2090314
|
LY 2090314
|
603288-22-8
|
|
ITMN 4077
|
((2R,6S,13AS,14AR,16AS,Z)-14A - ((環(huán)丙基磺?；?氨基甲?；?-2-
|
790305-05-4
|
|
CID 16020046
|
4-[4,6-二氫-4-(3-羥基苯基)-3-(4-甲基苯基)-6-氧代吡咯并[3,4-C]吡唑-5(1H)-基]苯甲酸
|
834903-43-4
|
|
Beclabuvir
|
Beclabuvir
|
958002-33-0
|
|
AB-423
|
AB-423
|
1572510-80-5
|
|
JNJ-632
|
JNJ-632
|
1572510-42-9
|
|
Iclepertin
|
BI-425809
|
1421936-85-7
|
|
RG7834
|
RO 7020322
|
2072057-17-9
|
|
GSTO1-IN-1
|
568544-03-6
|
568544-03-6
|
|
GRK6-IN-2
|
化合物 GRK6-IN-2
|
2677786-27-3
|
|
EIDD-1931
|
N-羥基胞苷
|
3258-02-4
|
|
Taribavirin hydrochloride
|
TARIBAVIRIN HYDROCHLORIDE
|
40372-00-7
|
|
Ezatiostat hydrochloride
|
L-GAMMA-谷氨?；?S-芐基-L-半胱氨酰基-2-苯基甘氨酸二乙酯鹽酸鹽
|
286942-97-0
|
|
SSR504734
|
2-氯-3-(三氟甲基)-N-((S)-苯基((S)-哌啶-2-基)甲基)苯甲酰胺鹽酸鹽
|
615571-23-8
|
|
Paritaprevir
|
ABT450
|
1216941-48-8
|
|
Phen-DC3 Trifluoromethanesulfonate
|
929895-45-4
|
929895-45-4
|
|
2-Di-1-ASP
|
2-[4-(二甲基氨基)苯乙烯基]-1-甲基吡啶碘化物
|
2156-29-8
|
|
TP-024
|
化合物FTBMT
|
1358575-02-6
|
|
BRD0705
|
BRD0705
|
2056261-41-5
|
|
Morphothiadin
|
莫非賽定
|
1092970-12-1
|
|
Osalmid
|
柳胺酚
|
526-18-1
|
|
BMS-378806
|
1-[(2R)-4-苯甲?；?2-甲基-1-哌嗪基]-2-(4-甲氧基-1H-吡咯并[2,3-B]吡啶-3-基)-1,2-乙二酮
|
357263-13-9
|
|
Bisindolylmaleimide I hydrochloride
|
3-[1-[3-(二甲基氨基)丙基]-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮單鹽酸鹽
|
176504-36-2
|
|
Zagociguat
|
ZAGOCIGUAT
|
2201048-82-8
|
|
2'-C-Methyladenosine
|
2'-C-甲基腺苷
|
15397-12-3
|
|
PF-05212384 (PKI-587)
|
N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N'-[4-[4,6-二(4-嗎啉基)-1,3,5-三嗪-2-基]苯基]脲
|
1197160-78-3
|
|
AZD2858
|
AZD2858
|
486424-20-8
|
|
Torcitabine
|
2'-脫氧-L-胞苷
|
40093-94-5
|
|
NCRW0005-F05
|
化合物NCRW0005-F05
|
342779-66-2
|
|
ABT-072
|
1132936-00-5
|
1132936-00-5
|
|
Ledipasvir-d6
|
|
2050041-12-6
|
|
SAR502250
|
SAR502250
|
503860-57-9
|
|
MS48107
|
化合物MS48107
|
2375070-79-2
|
|
Tenofovir amibufenamide
|
艾米替諾福韋
|
1571076-26-0
|
|
Ledipasvir (acetone)
|
雷迪帕韋單丙酮溶劑化物
|
1441674-54-9
|
|
BIP-135
|
3-(5-BroMo-1-Methyl-1H-indol-3-yl)-4-(benzofuran-3-yl)pyrrole-2,5-dione
|
941575-71-9
|
|
HCV-IN-30
|
達(dá)卡他韋中間體II
|
1007882-23-6
|
|
JNJ-63533054
|
3-氯-N-[2-氧代-2-[[(1S)-1-苯基乙基]氨基]乙基]苯甲酰胺
|
1802326-66-4
|
|
Cavosonstat
|
CAVOSONSTAT (N91115)
|
1371587-51-7
|
|
NVR 3-778
|
4-fluoro-3-((4-hydroxypiperidin-1-yl)sulfonyl)-N-(3,4,5-trifluorophenyl)benzamide
|
1445790-55-5
|
|
Telbivudine
|
替比夫定
|
3424-98-4
|
|
CID1231538
|
N-{2-[(4-chlorobenzyl)sulfanyl]-1,3-benzothiazol-6-yl}-2-(morpholin-4-ylcarbonyl)benzamide
|
354126-20-8
|
|
Plecanatide acetate
|
PLECANATIDE ACETATE
|
1075732-84-1
|
|
PF-03463275
|
N-[(3-氯-4-氟苯基)甲基]-1-甲基-N-[[(1ALPHA,5ALPHA,6ALPHA)-3-甲基-3-氮雜雙環(huán)[3.1.0]己烷-6-基]甲基]-1H-咪唑-4-甲酰胺鹽酸鹽
|
1173239-39-8
|
|
BMVC2
|
o-BMVC
|
850559-51-2
|
|
CVN424
|
Ethanone, 1-[2-[4-(2,4-difluorophenoxy)-1-piperidinyl]-7,8-dihydro-3-[[(3R)-tetrahydro-3-furanyl]amino]pyrido[3,4-b]pyrazin-6(5H)-yl]-
|
2254706-21-1
|
|
GSK3-IN-1
|
2-((2-氯芐基)硫基)-5-(吡啶-4-基)-1,3,4-惡二唑
|
478482-74-5
|
|
APD597
|
APD597
|
897732-93-3
|
|
MitMAB
|
N,N,N-三甲基-1-十四烷基溴化銨
|
1119-97-7
|
|
CFM 1571 hydrochloride
|
CFM 1571 Hydrochloride
|
1215548-30-3
|
|
(Rac)-MGV354
|
MGV354
|
1852495-86-3
|
|
Runcaciguat
|
RUNCACIGUAT
|
1402936-61-1
|
|
GPR84 antagonist 8
|
GPR84 ANTAGONIST 8
|
1445846-30-9
|
|
Valopicitabine dihydrochloride
|
Valopicitabine dihydrochloride
|
640725-71-9
|
|
GLPG1205
|
9-(2-環(huán)丙基乙炔基)-2-[((2S)-1,4-二惡烷-2-基甲氧基]-6,7-二氫-4H-嘧啶[6,1-a]異喹啉-4-酮
|
1445847-37-9
|
|
HCV-IN-31
|
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)-
|
1998705-62-6
|
|
GRK5-IN-2
|
化合物GRK5-IN-2
|
1642839-27-7
|
|
Riociguat
|
利奧西呱
|
625115-55-1
|
|
BMS-986094
|
N-(2'-C-甲基-6-O-甲基-P-1-萘基-5'-鳥苷?；?-L-丙氨酸 2,2-二甲基丙酯
|
1234490-83-5
|
|
APD668
|
APD668
|
832714-46-2
|
|
Merimepodib
|
MERIMEPODIB
|
198821-22-6
|
|
Fluoroorotic Acid, Ultra Pure
|
5-氟乳清酸
|
703-95-7
|
|
Sofosbuvir impurity M
|
索非布韋雜質(zhì)M
|
2095551-10-1
|
|
Carboxy pyridostatin trifluoroacetate salt
|
CARBOXYPYRIDOSTATIN TRIFLUOROACETATE SALT
|
2444713-88-4
|
|
Bemnifosbuvir hemisulfate
|
AT-527
|
2241337-84-6
|
|
MM 419447
|
利那洛肽代謝物
|
1092457-78-7
|
|
MM41
|
化合物 MM41
|
1429028-96-5
|
|
LP-471756
|
化合物 T27850
|
413605-11-5
|
|
MK-0608
|
(2R,3R,4R,5R)-2-(4-氨基-7H-吡咯并[2,3-D]嘧啶-7-基)-5-(羥甲基)-3-甲基四氫呋喃-3,4-二醇
|
443642-29-3
|
|
Ezatiostat
|
EZATIOSTAT游離的
|
168682-53-9
|
|
AZD1080
|
AZD1080
|
612487-72-6
|
|
SC 144
|
吡嗪羧酸 2-(7-氟吡咯并[1,2-A]喹喔啉-4-基)酰肼
|
895158-95-9
|
|
Bicyclol
|
雙環(huán)醇
|
118159-48-1
|
|
Inarigivir soproxil
|
INARIGIVIR SOPROXIL
|
942123-43-5
|
|
NE 52-QQ57
|
2-(4-((2-ethyl-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)methyl)phenyl)-5-(piperidin-4-yl)-1,3,4-oxadiazole
|
1401728-56-0
|
|
TAK-041
|
1929519-13-0
|
1929519-13-0
|
|
Firuglipel
|
FIRUGLIPEL
|
1371591-51-3
|
|
DDX3-IN-1
|
DDX3-IN-1
|
1919828-83-3
|
|
PW0787
|
1-(6-(3-氟-5-(三氟甲基)芐基)嘧啶-4-基)-N-(2-羥乙基)吲哚啉-4-甲酰胺
|
2624131-45-7
|
|
Inarigivir ammonium
|
INARIGIVIR銨
|
2172788-92-8
|
|
Linaclotide
|
利那洛肽
|
851199-59-2
|
|
GSK1292263
|
GSK1292263
|
1032823-75-8
|
|
CP21R7
|
GSK-3Β抑制劑(CP21R7)
|
125314-13-8
|
|
Samatasvir
|
ATOLIHZIXHZSBA-BTSKBWHGSA-N
|
1312547-19-5
|
|
EIDD-2749
|
4'-C-Fluoro-uridine
|
1613589-24-4
|
|
Bemnifosbuvir
|
L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester
|
1998705-64-8
|
|
HBF-0259
|
Tetrazolo[1,5-a]pyrimidine, 7-(2-chloro-6-fluorophenyl)-5-(4-chlorophenyl)-1,5,6,7-tetrahydro-
|
957011-15-3
|
|
Furaprofen
|
呋喃洛芬
|
67700-30-5
|
|
ABT-072 potassium trihydrate
|
ABT-072 POTASSIUM TRIHYDRATE
|
1132940-31-8
|
|
NIM811
|
NIM811
|
143205-42-9
|
|
N6022
|
N6022
|
1208315-24-5
|
|
Voxilaprevir
|
維昔普維
|
1535212-07-7
|
|
2'-O-Methylcytidine
|
2'-甲氧基胞苷
|
2140-72-9
|
|
Vebicorvir
|
ABI-H0731
|
2090064-66-5
|
|
AR-A014418
|
AR-A 014418
|
487021-52-3
|